US Stock MarketDetailed Quotes

Impact BioMedical (IBO)

Watchlist
  • 0.5376
  • -0.0124-2.25%
Close May 15 16:00 ET
  • 0.5100
  • -0.0276-5.13%
Post 20:01 ET
57.96MMarket Cap-1.85P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Impact BioMedical (IBO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
31.96%-464K
33.78%-1.89M
110.04%99K
38.76%-613K
-80.26%-694K
-41.49%-682K
-0.11%-2.85M
-127.71%-986K
-49.18%-1M
47.48%-385K
Net income from continuing operations
-78.72%-2.28M
52.08%-11.87M
119.29%5.24M
-134.74%-1.47M
-1,527.32%-14.35M
-28.06%-1.28M
-462.06%-24.77M
-2,051.70%-27.13M
460.49%4.24M
21.25%-882K
Operating gains losses
----
--12K
----
----
----
----
----
----
----
----
Depreciation and amortization
0.71%285K
2.32%1.15M
2.51%286K
2.49%288K
3.23%288K
1.07%283K
-0.09%1.12M
-0.36%279K
0.36%281K
-0.36%279K
Deferred tax
----
-7,918.18%-2.58M
----
----
----
----
--33K
----
----
----
Other non cash items
----
359.08%10.37M
295.66%9.39M
-7.75%262K
60.14%450K
17.83%271K
---4M
---4.8M
--284K
--281K
Change In working capital
763.64%95K
198.68%600K
231.31%541K
130.22%42K
109.52%6K
83.33%11K
-239.45%-608K
-175.18%-412K
-161.50%-139K
-158.88%-63K
-Change in receivables
--5K
-100.78%-1K
--10K
-111.72%-15K
--4K
--0
200.00%128K
--0
36.17%128K
----
-Change in inventory
----
--7K
--3K
--1K
----
----
--0
--0
--0
----
-Change in prepaid assets
-51.55%47K
147.55%126K
-37.00%63K
89.16%-35K
102.50%1K
4,950.00%97K
-354.81%-265K
4.17%100K
-559.18%-323K
-129.41%-40K
-Change in payables and accrued expense
150.00%43K
199.36%468K
190.82%465K
62.50%91K
91.30%-2K
-1,175.00%-86K
-202.39%-471K
-188.28%-512K
-69.06%56K
-135.38%-23K
Cash from discontinued investing activities
Operating cash flow
31.96%-464K
33.78%-1.89M
110.04%99K
38.76%-613K
-80.26%-694K
-41.49%-682K
-0.11%-2.85M
-127.71%-986K
-49.18%-1M
47.48%-385K
Investing cash flow
Cash flow from continuing investing activities
-200.00%-1K
50.00%3K
1K
0.00%1K
0
1K
113.33%2K
0
200.00%1K
109.09%1K
Net PPE purchase and sale
----
----
----
----
----
----
--0
--0
--0
--0
Net other investing changes
-200.00%-1K
50.00%3K
--1K
0.00%1K
--0
--1K
-33.33%2K
--0
--1K
----
Cash from discontinued investing activities
Investing cash flow
-200.00%-1K
50.00%3K
--1K
0.00%1K
--0
--1K
113.33%2K
--0
200.00%1K
109.09%1K
Financing cash flow
Cash flow from continuing financing activities
482K
-102.25%-109K
-134.38%-109K
0
0
0
69.28%4.85M
36.64%317K
321.38%3.67M
-48.53%384K
Net issuance payments of debt
--482K
-109.70%-109K
-134.38%-109K
--0
--0
--0
-60.77%1.12M
36.64%317K
-106.90%-60K
-48.53%384K
Net common stock issuance
----
--0
--0
----
----
----
--3.73M
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--482K
-102.25%-109K
-134.38%-109K
--0
--0
--0
69.28%4.85M
36.64%317K
321.38%3.67M
-48.53%384K
Net cash flow
Beginning cash position
-99.85%3K
199,800.00%2M
-99.55%12K
31,100.00%624K
65,800.00%1.32M
199,800.00%2M
-50.00%1K
1,227.36%2.67M
-33.33%2K
100.00%2K
Current changes in cash
102.50%17K
-199.90%-2M
98.65%-9K
-122.96%-612K
---694K
-68,200.00%-681K
199,900.00%2M
-234.50%-669K
1,246.46%2.67M
--0
End cash Position
-98.48%20K
-99.85%3K
-99.85%3K
-99.55%12K
31,100.00%624K
65,800.00%1.32M
199,800.00%2M
199,800.00%2M
1,227.36%2.67M
-33.33%2K
Free cash flow
31.96%-464K
33.78%-1.89M
110.04%99K
38.76%-613K
-80.26%-694K
-41.49%-682K
0.52%-2.85M
-127.71%-986K
-48.96%-1M
48.32%-385K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 31.96%-464K33.78%-1.89M110.04%99K38.76%-613K-80.26%-694K-41.49%-682K-0.11%-2.85M-127.71%-986K-49.18%-1M47.48%-385K
Net income from continuing operations -78.72%-2.28M52.08%-11.87M119.29%5.24M-134.74%-1.47M-1,527.32%-14.35M-28.06%-1.28M-462.06%-24.77M-2,051.70%-27.13M460.49%4.24M21.25%-882K
Operating gains losses ------12K--------------------------------
Depreciation and amortization 0.71%285K2.32%1.15M2.51%286K2.49%288K3.23%288K1.07%283K-0.09%1.12M-0.36%279K0.36%281K-0.36%279K
Deferred tax -----7,918.18%-2.58M------------------33K------------
Other non cash items ----359.08%10.37M295.66%9.39M-7.75%262K60.14%450K17.83%271K---4M---4.8M--284K--281K
Change In working capital 763.64%95K198.68%600K231.31%541K130.22%42K109.52%6K83.33%11K-239.45%-608K-175.18%-412K-161.50%-139K-158.88%-63K
-Change in receivables --5K-100.78%-1K--10K-111.72%-15K--4K--0200.00%128K--036.17%128K----
-Change in inventory ------7K--3K--1K----------0--0--0----
-Change in prepaid assets -51.55%47K147.55%126K-37.00%63K89.16%-35K102.50%1K4,950.00%97K-354.81%-265K4.17%100K-559.18%-323K-129.41%-40K
-Change in payables and accrued expense 150.00%43K199.36%468K190.82%465K62.50%91K91.30%-2K-1,175.00%-86K-202.39%-471K-188.28%-512K-69.06%56K-135.38%-23K
Cash from discontinued investing activities
Operating cash flow 31.96%-464K33.78%-1.89M110.04%99K38.76%-613K-80.26%-694K-41.49%-682K-0.11%-2.85M-127.71%-986K-49.18%-1M47.48%-385K
Investing cash flow
Cash flow from continuing investing activities -200.00%-1K50.00%3K1K0.00%1K01K113.33%2K0200.00%1K109.09%1K
Net PPE purchase and sale --------------------------0--0--0--0
Net other investing changes -200.00%-1K50.00%3K--1K0.00%1K--0--1K-33.33%2K--0--1K----
Cash from discontinued investing activities
Investing cash flow -200.00%-1K50.00%3K--1K0.00%1K--0--1K113.33%2K--0200.00%1K109.09%1K
Financing cash flow
Cash flow from continuing financing activities 482K-102.25%-109K-134.38%-109K00069.28%4.85M36.64%317K321.38%3.67M-48.53%384K
Net issuance payments of debt --482K-109.70%-109K-134.38%-109K--0--0--0-60.77%1.12M36.64%317K-106.90%-60K-48.53%384K
Net common stock issuance ------0--0--------------3.73M--0--------
Cash from discontinued financing activities
Financing cash flow --482K-102.25%-109K-134.38%-109K--0--0--069.28%4.85M36.64%317K321.38%3.67M-48.53%384K
Net cash flow
Beginning cash position -99.85%3K199,800.00%2M-99.55%12K31,100.00%624K65,800.00%1.32M199,800.00%2M-50.00%1K1,227.36%2.67M-33.33%2K100.00%2K
Current changes in cash 102.50%17K-199.90%-2M98.65%-9K-122.96%-612K---694K-68,200.00%-681K199,900.00%2M-234.50%-669K1,246.46%2.67M--0
End cash Position -98.48%20K-99.85%3K-99.85%3K-99.55%12K31,100.00%624K65,800.00%1.32M199,800.00%2M199,800.00%2M1,227.36%2.67M-33.33%2K
Free cash flow 31.96%-464K33.78%-1.89M110.04%99K38.76%-613K-80.26%-694K-41.49%-682K0.52%-2.85M-127.71%-986K-48.96%-1M48.32%-385K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -